The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
PERIPHERAL INTERVENTIONS
Novel PARADIGM in carotid revascularisation: Prospective evaluation of All-comer peRcutaneous cArotiD revascularisation in symptomatic and Increased-risk asymptomatic carotid artery stenosis using CGuard™ MicroNet-covered embolic prevention stent system
EuroIntervention 2016;12:e658-e670 published online ahead of print May 2016 published online e-edition August 2016. DOI: 10.4244/EIJY16M05_02
Piotr Musialek1*, MD, DPhil; Adam Mazurek1, MD; Mariusz Trystula2, MD, PhD; Anna Borratynska3, MD, PhD; Agata Lesniak-Sobelga1, MD, PhD; Malgorzata Urbanczyk4, MD; R. Pawel Banys4, MSc; Andrzej Brzychczy2, MD, PhD; Wojciech Zajdel5, MD, PhD; Lukasz Partyka6, MD, PhD; Krzysztof Zmudka5, MD, PhD; Piotr Podolec1, MD, PhD
1. Jagiellonian University Department of Cardiac & Vascular Diseases, John Paul II Hospital, Krakow, Poland; 2. Department of Vascular Surgery, John Paul II Hospital, Krakow, Poland; 3. Neurology Outpatient Department, John Paul II Hospital, Krakow, P
Aims: Our aim was to determine (1) periprocedural and 30-day clinical safety and efficacy of the CGuard MicroNet-covered embolic prevention carotid stent system (MN-EPS) in routine use fo